143 plasma renin concentration alone provides an overlapping zone. Moreover, effective plasma renin correlates significantly with mean blood pressure, whereas plasma renin concentration alone does not.
Introduction
In the drug treatment of hyperthyroidism it has been customary to use thiourea derivatives in a divided daily regimen, titrating dosage against clinical and biochemical thyroid status and only occasionally adding thyroid hormone replacement to prevent or correct iatrogenic hypothyroidism.
This approach carries certain disadvantages-the need for periodic and sometimes frequent evaluation to prevent swings Royal Adelaide Hospital, Adelaide, South Australia P. H. WISE, M.R.C.P., F.R.A.C.P., Director of Endocrinology Institute of Medical and Veterinary Science, Adelaide, South Australia MILLICENT MARION, M.B., B.S., Physician in Nuclear Medicine R. W. PAIN, M.B., F.R.C.P.A., Clinical Chemist (Medical) in thyroid status and the unreliability of clinical assessment of euthyroidism, especially when using propylthiouracil (Christensen et al., 1969) and in the early months of treatment where normal serum thyroxine (T-4) levels may not reflect euthyroid secretory pattern to disproportionately high triiodothyronine (T-3) concentrations (BeUabarba et al., 1972 J Hypothyroid levels of the free thyroxine index during treatment confirmed subtotal block of hormone synthesis. To provide an additional assessment of completeness of block the following procedure was undertaken. The mean free thyroxine index in the above treated hyperthyroid patients was compared with the mean index in a group of subjects with simple obesity during treatment with triiodothyronine 80 ,ug daily for a minimum period of three months. The respective values for these groups (3 7±0 7; 3-6+0 6) did not differ significantly (P >0-1) ( fig. 3 ).
This suggests that the 40 mg dose of carbimazole was as effective in reducing circulating thyroxine levels as a dose of triiodothyronine, known from other studies to be almost invariably capable of suppressing production of thyroid stimulating hormone (Cotton et al., 1971) .
It should be noted that all the stated free thyroxine indices were based on thyroxine assays which employed extrapolations from the usual linear form of standard "curve" and therefore falsely raised any thyroxine values falling within the hypothyroid range. Accordingly a thyroxine assay using a precise sigmoid standard curve, employing multiple concentrations of thyroxine standard from zero to 15 ,ug/100 ml, was set up for 12 sera from patients on block-replace therapy. A "true" free thyroxine index of 13±0 4 compared with a "standard" index of 3 3±0 5 was obtained on this group, thereby providing a better indication of the degree of impairment of hormone synthesis achieved by this therapy.
All patients volunteered appreciation of single daily dosage, and in eight cases a further improvement in patient acceptance was achieved through the use of specially prepared capsules 144 t L 145 containing carbimazole 10 mg and triiodothyronine 20 ,ug. All patients were willing to continue single-dose therapy indefinitely. One patient developed a typical erythematous rash and migratory polyarthralgia assumed to represent hypersensitivity to carbimazole and was transferred, with maintenance of block, to propylthiouracil in divided dosage. Conversion to equivalent single daily dosage of this drug (400 mg), however, was associated with loss of control, and the patient subsequently requested surgical management.
Discussion
Despite the lack of conclusive evidence on either teratogenicity or carcinogenicity resulting from radioiodine therapy for hyperthyroidism it is still generally considered inadvisable to use this mode of therapy in the reproductive age group. Recurrence rates after subtotal thyroidectomy (14%) and the incidence of postoperative hypothyroidism (25%), both reported in a series of 5,221 subjects in a multicentre study (Becker et al., 1971) , suggest that there is a continued place for prolonged antithyroid therapy in many cases of hyperthyroidism. Methods which improve stability of control, reduce doctor or hospital visits to a minimum, and improve patient acceptance justify close examination.
Two previous studies of relevance have been reported. Greer et al. (1965) used single daily doses of propylthiouracil or methimazole and claimed control in 29 out of 31 cases; however, no laboratory data were included to support this claim and titration of dose against clinical and biochemical status was still employed. More recently Kammer and Srinivasan (1969) reported that out of 41 patients controlled on propylthiouracil in divided doses, 28 were able to continue on single daily doses with clinical and biochemical control using doses of up to 400 mg daily. In that paper it was suggested that methimazole, the active metabolite of carbimazole, could prove more effective for single-dose therapy because of its longer duration of action (Stanley and Astwood, 1949) . Recent studies confirm selective binding of both methimazole and propylthiouracil into thyroid tissue (Pittman et al., 1971) , and the data of Wartofsky and Ingbar (1971) indicate a duration of action of a single dose of 30 mg methimazole of 24-36 hours despite the shorter biological half-life when assessed on blood levels. This indicates that single daily administration of these drugs in sufficient dosage should indeed be effective in adequately inhibiting thyroid hormone biosynthesis.
Barnes and Bledsoe (1972) described an overall 68% response rate to single-dose methimazole therapy and suggested that high perchlorate discharge provided a positive discriminant for such responses. The universal ability to maintain block with single-dose therapy in the present series may be based on the slightly higher doses of antithyroid drug used, a presently undefined advantage of carbimazole compared with its metabolite methiamzole, or on adequate thyroidal block shown before the change from divided to single daily dosage.
Though divided doses of carbimazole up to 60 mg daily are occasionally necessary to achieve adequate blocking this was not found in the present consecutive series. Whether such higher doses would allow conversion to single-dose administration remains to be seen. Though triiodothyronine 80 ,ug daily was accepted as close to the expected replacement dosage at initiation of this study in 1970, subsequent studies utilizing the principle of plasma thyrotrophin responsiveness to intravenous thyrotrophin-releasing hormone (Schenkman et al., 1973) should help in determining precisely whether this dosage of triiodothyronine is physiologically correct in patients with subtotally blocked glands. Current limited studies in this unit suggest that the present 80 itg dose may be excessive replacement even in totally athyroid subjects.
The point at which to stop antithyroid therapy is controversial, and this problem falls outside the scope of this report. Nevertheless, suppressibility of thyroid trapping assessed at intervals after starting therapy has been used as a basis for termination of therapy (Alexander et al., 1970) . The constant administration of triiodothyronine in the above treatment regimen allows easy assessment of such suppressibility without need for change in drug procedure. The rate of achievement of suppressibility in an extended series treated in this manner will be reported later.
The above treatment programme has been extended to six additional hyperthyroid patients with multinodular glands and has given equally satisfactory responses. More definitive forms of therapy, however, are likely to predominate in this variety of hyperthyroidism.
The relative stability of thyroid function with block-replace therapy has enabled biochemical and clinical assessments to be reduced with complete confidence to six-monthly or yearly intervals in 12 patients for whom antithyroid drugs provided definitive therapy. This was considered particularly valuable in six patients living remote from medical observation and laboratory facilities. Even allowing for the occasional failure of singledose, block-replace therapy likely to occur in a larger series, its acceptability to patients, together with the increasingly welldefined morbidity of subtotal thyroidectomy referred to above, suggest that this regimen might be employed with advantage on a wider scale.
